OMEROS CORP Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
OMEROS CORP (OMER) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.09 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2026-08-12
- OMEROS CORP income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2026-06-30 was $0.09, a 800.00% increase year-over-year.
- OMEROS CORP income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2026-03-31 was $0.07, a 0.00% change year-over-year.
- OMEROS CORP income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2025-09-30 was -$0.15, a 287.50% decline year-over-year.
- OMEROS CORP income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2025-06-30 was $0.01, a 93.33% decline year-over-year.
- OMEROS CORP income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2025 was $0.03, a 93.18% decline from fiscal 2024.
- OMEROS CORP income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2024 was $0.44, a 51.65% decline from fiscal 2023.
- OMEROS CORP income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2023 was $0.91, a 75.14% decline from fiscal 2022.
- OMEROS CORP income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2022 was $3.66, a 40.87% decline from fiscal 2021.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.09 10-Q · filed 2026-08-12 | $0.16 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $0.07 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $0.03 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$0.15 10-Q · filed 2025-11-13 | -$0.08 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.01 10-Q · filed 2026-08-12 | $0.08 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $0.07 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $0.44 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $0.08 10-Q · filed 2025-11-13 | $0.36 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $0.15 10-Q · filed 2025-08-14 | $0.27 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $0.12 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $0.91 10-K · filed 2026-03-31 | |||
| 2023-09-30 | $0.22 10-Q · filed 2024-11-13 | $0.43 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $0.11 10-Q · filed 2024-08-07 | $0.21 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $0.09 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $3.66 10-K · filed 2025-03-31 | |||
| 2022-09-30 | $0.59 10-Q · filed 2023-11-09 | $0.87 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.17 10-Q · filed 2023-08-09 | $0.28 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.10 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $6.19 10-K · filed 2024-04-01 | |||
| 2021-09-30 | $0.34 10-Q · filed 2022-11-09 | $0.93 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.34 10-Q · filed 2022-08-09 | $0.59 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.24 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $0.61 10-K · filed 2023-03-13 | |||
| 2019-12-31 | $1.27 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |